Raffi Asadorian, Chief Financial Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 3,647 shares at $2.81 ($10K) on 2019-02-28, disclosed to the SEC on 2019-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACRX | BUY | 2018-12-17 | $14K | — | Filing → |
| ACRX | BUY | 2018-11-13 | $16K | — | Filing → |
| ACRX | BUY | 2018-08-06 | $14K | — | Filing → |